Pluro

Pluro, based in India, is a fertility care provider offering advanced reproductive technologies and personalized treatment plans to assist individuals and couples on their path to parenthood. Founded in 2025, Pluro operates in Mumbai, India, providing fertility solutions. The company secured INR 125. 000 mn in Series A funding on October 31, 2025, led by Bessemer Venture Partners, raising a total of INR 125.

000 mn. Pluro aims to expand its services in reproductive health through innovative strategies. Pluro specializes in comprehensive fertility care, offering advanced reproductive technologies and personalized treatment plans. Core services include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), egg and sperm donation, and fertility preservation.

They employ techniques like Preimplantation Genetic Testing (PGT) and donor embryo transfers, addressing fertility challenges and ensuring tailored care for clients across India. Pluro generates revenue through individual treatment cycles and associated services, focusing on direct-to-consumer transactions. Services offered include sperm freezing, egg retrieval, and specialized procedures such as laparoscopy and hysteroscopy, with transparent pricing strategies to aid client understanding of costs. In October 2025, Pluro raised INR 125.

000 mn in Series A funding to expand its network presence and enhance technology and clinical capabilities in advanced reproductive science. The company plans to launch new fertility solutions and aims to extend its services into additional metropolitan regions across India by mid-2026.